← Leaderboards
Susana Tejeda-Garibay
University Of California, Merced
$97,851
Attributed
$97,851
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $39.2K · FY2021–23$50K$37.5K$25K$12.5K$0
'21
'22
'23
Funding mix
By agency
NIH$97,851 · 1
By mechanism
F31$97,851 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Chronic”
- Jeffrey Reich · Sparian Biosciences, Inc.$21,671,295
- Priyamvada Acharya · Duke University$20,941,151
- Dale Sandler · Social And Scientific Systems, Inc.$18,360,118
- Steven Schachter · Massachusetts General Hospital$18,327,380
- Suparna Goswami · Univ Of North Carolina Chapel Hill$16,919,767
- Abraham Aizer Brody · New York University School Of Medicine$15,928,507
Research focus
ChronicChronic DiseaseAerosolized16s Ribosomal Rna SequencingAffectAcute DiseaseAntibiotic ResistanceAntibioticsAntibiotic TherapyAccurate DiagnosisAsthmaBacteriaBacterial PneumoniaBacterial ResistanceBronchoalveolar LavageCancer EtiologyCd4 Positive T LymphocytesCd8b1 GeneCd8-Positive T-LymphocytesCell Differentiation ProcessCellsAntifungal AgentsCentral AmericaChronic Infection
Grant awards (3)
Defining the State of CD8+ and CD4+ T cells and the Effect of Antibiotic Treatment on Chronic States of Coccidioidomycosis Disease$20,079
F31 · FY2023 · HL · contact PI
Defining the State of CD8+ and CD4+ T cells and the Effect of Antibiotic Treatment on Chronic States of Coccidioidomycosis Disease$39,244
F31 · FY2022 · HL · contact PI
Defining the State of CD8+ and CD4+ T cells and the Effect of Antibiotic Treatment on Chronic States of Coccidioidomycosis Disease$38,528
F31 · FY2021 · HL · contact PI